OTCQX:CNXXF - Post by User
Post by
Chris2982on Oct 16, 2018 9:34am
53 Views
Post# 28808824
All we can do is look at the fundamentals
All we can do is look at the fundamentalsSome bad news for sure but let’s remember why this company is still attractive:
GTII last quarter (US millions):
revenue: 13.6
adjusted EBITDA: .5
Market cap: 2850
MedMen:
Revenue:19.2
EBITDA: didn’t realease but probably very negative
market cap: 2500
cannex:
revenue: 3.4 (or 10.3 if you include all NWCS earnings)
EBITDA: 1.78
market cap: 120
In other words the market values MedMen and green thumb as being worth 20X MORE than cannex even though they have comparable revenue. Now mmen and gtii should command a premium because they already have an established presence in a lot of states vs just one for cannex but I think we can all agree that the valuation for cannex is extraordinarily low compared to the industry considering they have the same growth prospects as every other US player